Human Genome (HGSI), Glaxo (GSK) report FDA priority review for Benlysta for Lupus; Says PDUFA date Dec. 9
Tweet Send to a Friend
Human Genome (Nasdaq: HGSI) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
